H. Christensen, M. May, L. Bowen, M. Hickman, and C. L. Trotter, Meningococcal carriage by age: a 363 systematic review and meta-analysis, Lancet Infect Dis, vol.10, pp.853-61, 2010.

D. A. Caugant and M. C. Maiden, Meningococcal carriage and disease--population biology and evolution, Vaccine, vol.365, issue.2, pp.64-70, 2009.
DOI : 10.1016/j.vaccine.2009.04.061
URL : https://doi.org/10.1016/j.vaccine.2009.04.061

S. P. Yazdankhah, P. Kriz, and G. Tzanakaki, Distribution of serogroups and genotypes among 367 disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, 368 and Norway, J Clin Microbiol, vol.42, pp.5146-53, 2004.

L. A. Lewis and S. Ram, Meningococcal disease and the complement system, Virulence, vol.5, pp.98-126, 2014.
DOI : 10.4161/viru.26515
URL : https://www.tandfonline.com/doi/pdf/10.4161/viru.26515?needAccess=true

N. S. Merle, R. Noe, L. Halbwachs-mecarelli, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System, p.371

, Part II: Role in Immunity. Front Immunol, vol.6, p.257, 2015.

M. C. Schneider, B. E. Prosser, and J. J. Caesar, Neisseria meningitidis recruits factor H using protein 373 mimicry of host carbohydrates, Nature, vol.458, pp.890-893, 2009.

D. Bubeck, The making of a macromolecular machine: assembly of the membrane attack complex, Biochemistry, vol.375, pp.1908-1923, 2014.

M. Botto, M. Kirschfink, P. Macor, M. C. Pickering, R. Wurzner et al., Complement in human, vol.377

X. Wang, D. T. Fleischer, and W. T. Whitehead, Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families, J Immunol, vol.154, pp.5464-71, 1995.

R. Arnaout, A. Shorbaghi, S. , A. Dhekri, and H. , C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review, J Clin Immunol, vol.33, pp.871-876, 2013.

E. P. Owen, R. Wurzner, and F. Leisegang, A complement C5 gene mutation, c.754G>A:p.A252T, is common in the Western Cape, South Africa and found to be homozygous in seven percent of Black African meningococcal disease cases, Mol Immunol, vol.64, pp.170-176, 2015.

R. Colobran, C. Franco-jarava, and A. Martin-nalda, Novel Mutations Causing C5 Deficiency in Three North-African Families, J Clin Immunol, vol.36, pp.388-96, 2016.

K. L. Parham, A. Roberts, and A. Thomas, Prevalence of mutations leading to complete C6 deficiency (C6Q0) in the Western Cape, South Africa and detection of novel mutations leading to C6Q0 in an Irish family, Mol Immunol, vol.44, pp.2756-60, 2007.

M. R. Moya-quiles, M. V. Bernardo-pisa, and P. Martinez, Complement component C6 deficiency in a Spanish family: implications for clinical and molecular diagnosis, Gene, vol.521, pp.204-210, 2013.

Z. Zhu, T. P. Atkinson, and K. T. Hovanky, High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA, Clin Exp Immunol, vol.119, pp.305-315, 2000.

M. A. Dragon-durey, V. Fremeaux-bacchi, J. Blouin, D. Barraud, W. H. Fridman et al., Restricted genetic defects underlie human complement C6 deficiency, Clin Exp Immunol, vol.132, pp.87-91, 2003.

M. J. Hobart, B. A. Fernie, K. A. Fijen, and A. Orren, The molecular basis of C6 deficiency in the western Cape, South Africa, Hum Genet, vol.103, pp.506-518, 1998.

Z. B. Zhu, K. Totemchokchyakarn, T. P. Atkinson, and J. E. Volanakis, Molecular defects leading to human complement component C6 deficiency in an African-American family, Clin Exp Immunol, vol.111, pp.91-97, 1998.

A. Orren, E. P. Owen, and H. E. Henderson, Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans, Clin Exp Immunol, vol.167, pp.459-71, 2012.

H. Nishizaka, T. Horiuchi, and Z. B. Zhu, Molecular bases for inherited human complement component C6 deficiency in two unrelated individuals, J Immunol, vol.156, pp.2309-2324, 1996.

M. A. Rameix-welti, C. H. Regnier, and F. Bienaime, Hereditary complement C7 deficiency in nine families: subtotal C7 deficiency revisited, Eur J Immunol, vol.37, pp.1377-85, 2007.

C. S. Ki, J. W. Kim, and H. J. Kim, Two novel mutations in the C7 gene in a Korean patient with complement C7 deficiency, J Korean Med Sci, vol.20, pp.220-224, 2005.

H. J. Kang, C. S. Ki, Y. S. Kim, M. Hur, S. I. Jang et al., Two mutations of the C7 gene, c.1424G > A and c.281-1G > T, in two Korean families, J Clin Immunol, vol.26, pp.186-91, 2006.

S. Barroso, C. Rieubland, J. Alvarez, and A. , Molecular defects of the C7 gene in two patients with complement C7 deficiency, Immunology, vol.118, pp.257-60, 2006.

B. A. Fernie and M. J. Hobart, Complement C7 deficiency: seven further molecular defects and their associated marker haplotypes, Hum Genet, vol.103, pp.513-522, 1998.

M. F. Vazquez-bermudez, S. Barroso, and K. Walter, Complement component C7 deficiency in a Spanish family, Clin Exp Immunol, vol.133, pp.240-246, 2003.

S. Barroso, B. Sanchez, and A. J. Alvarez, Complement component C7 deficiency in two Spanish families, Immunology, vol.113, pp.518-541, 2004.

T. W. Kuijpers, M. Nguyen, and C. T. Hopman, Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease, Mol Immunol, vol.47, pp.671-678, 2010.

B. A. Fernie, R. Wurzner, and A. Orren, Molecular bases of combined subtotal deficiencies of C6 and C7: their effects in combination with other C6 and C7 deficiencies, J Immunol, vol.157, pp.3648-57, 1996.

R. Schirinzi, J. P. Lantin, V. Fremeaux-bacchi, J. A. Schifferli, and M. Trendelenburg,

, Med Klin (Munich), vol.101, pp.655-663, 2006.

L. Saucedo, L. Ackermann, A. E. Platonov, A. Gewurz, R. M. Rakita et al., Delineation of additional genetic bases for C8 beta deficiency. Prevalence of null alleles and predominance of C-->T transition in their genesis, J Immunol, vol.155, pp.5022-5030, 1995.

L. Rao, Y. B. Li, G. D. Chen, B. Zhou, P. M. Schneider et al.,

Z. Yi-xue-yi-chuan, Xue Za Zhi, vol.21, pp.10-13, 2004.

D. F. Arnold, A. G. Roberts, A. Thomas, B. Ferry, B. P. Morgan et al., A novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis, J Clin Immunol, vol.29, pp.691-696, 2009.

T. Kaufmann, G. Hansch, C. Rittner, P. Spath, F. Tedesco et al., Genetic basis of human complement C8 beta deficiency, J Immunol, vol.150, pp.4943-4950, 1993.

M. C. Pickering, P. Macor, and J. Fish, Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness, Rheumatology (Oxford), vol.47, pp.1588-1597, 2008.

K. Witzel-schlomp, P. J. Spath, and M. J. Hobart, The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure, J Immunol, vol.158, pp.5043-5052, 1997.

T. Horiuchi, H. Nishizaka, and T. Kojima, A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese, J Immunol, vol.160, pp.1509-1522, 1998.

M. Lek, K. J. Karczewski, and E. V. Minikel, Analysis of protein-coding genetic variation in 60,706 humans, Nature, vol.536, pp.285-91, 2016.

P. Hillmen, P. Muus, and A. Roth, Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria, Br J Haematol, vol.162, pp.62-73, 2013.

D. Vicente, O. Esnal, and E. Perez-trallero, Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates, J Infect, vol.64, pp.184-191, 2012.

H. Real, S. Vega-castano, S. , P. Garcia, and R. ,

, Enferm Infecc Microbiol Clin, 2016.

A. O. Applegate, V. C. Fong, K. Tardivel, S. A. Lippold, and S. Zarate, Notes from the Field: Meningococcal Disease in an International Traveler on Eculizumab Therapy -United States, MMWR Morb Mortal Wkly Rep, vol.65, pp.696-703, 2015.

C. Friedl, G. Hackl, G. Schilcher, A. R. Rosenkranz, K. Eller et al., Waterhouse-Friderichsen syndrome due to Neisseria meningitidis infection in a young adult with thrombotic microangiopathy and eculizumab treatment: case report and review of management, Ann Hematol, 2017.

S. J. Pittock, V. A. Lennon, and A. Mckeon, Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study, Lancet Neurol, vol.12, pp.554-62, 2013.

F. Fakhouri, M. Hourmant, and J. M. Campistol, Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial, Am J Kidney Dis, vol.68, pp.84-93, 2016.

G. H. Struijk, A. H. Bouts, G. T. Rijkers, E. A. Kuin, I. J. Ten-berge et al., Meningococcal sepsis complicating eculizumab treatment despite prior vaccination, Am J Transplant, vol.13, pp.819-839, 2013.